Association of insurance and race/ethnicity with disease severity among men diagnosed with prostate cancer, National Cancer Database 2004-2006

Cancer Epidemiology Biomarkers and Prevention

Volumn 19, Issue 10, 2010, Pages 2437-2444

  Fedewa, Stacey A ^a   Etzioni, Ruth ^c   Flanders, W Dana ^b   Jemal, Ahmedin ^a   Ward, Elizabeth M ^a  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; ASIAN; CANCER RESISTANCE; CANCER STAGING; CAUCASIAN; DATA BASE; DISEASE SEVERITY; ETHNICITY; GLEASON SCORE; HEALTH INSURANCE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; NEGRO; PRIORITY JOURNAL; PRIVATE HEALTH INSURANCE; PROSTATE CANCER; RACE DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; HUMANS; INSURANCE, HEALTH; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; UNITED STATES; YOUNG ADULT;

EID: 77958078031     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-0299     Document Type: Article

References (30)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225-49.
2. In: Horner MJRL, Krapcho M, Neyman N, et al, editors. SEER cancer statistics review, 1975-2006. Bethesda (MD): National Cancer Institute; 2008.
3. Partin AW, Mangold LA, Lamm DM, Walsh PC, Epstein JI, Pearson JD. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology 2001;58:843-8.
4. NCCN Clinical Practice Guidelines in Oncology Prostate Cancer V I. 2010: National Comprehensive Cancer Network; 2010.
5. Collaborative staging manual and coding instructions, version 01.04. 00. Chicago, IL Bethesda, MD: American Joint Committee on Cancer and U S. Department of Health and Human Services; 2004.
6. Shao YH, Demissie K, Shih W, et al. Contemporary risk profile of prostate cancer in the United States. J Natl Cancer Inst 2009;101: 1280-3.
7. Jani AB, Johnstone PA, Liauw SL, Master VA, Brawley OW. Age and grade trends in prostate cancer (1974-2003): a Surveillance, Epidemiology, and End ResultsRegistry analysis.AmJ Clin Oncol 2008;31:375-8.
8. Cooperberg MR, Cowan J, Broering JM, Carroll PR. High-risk prostate cancer in the United States, 1990-2007. World J Urol 2008;26: 211-8.
9. Dall'era MA, Hosang N, Konety B, Cowan JE, Carroll PR. Sociodemographic predictors of prostate cancer risk category at diagnosis: unique patterns of significant and insignificant disease. J Urol 2009; 181:1622-7, discussion 7.
10. Latini DM, Elkin EP, Cooperberg MR, Sadetsky N, Duchane J, Carroll PR. Differences in clinical characteristics and disease-free survival for Latino, African American, and non-Latino white men with localized prostate cancer: data from CaPSURE. Cancer 2006;106:789-95.
11. Hoffman RM, Gilliland FD, Eley JW, et al. Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study. J Natl Cancer Inst 2001;93:388-95.
12. Sadetsky N, Elkin EP, Latini DM, DuChane J, Carroll PR. Prostate cancer outcomes among older men: insurance status comparisons results from CaPSURE database. Prostate Cancer Prostatic Dis 2008;11:280-7.
13. Marlow NMHM, Pavluck AL, Ward EM, Chen AY. Disparities associated with advanced prostate cancer stage at diagnosis. J Health Care Poor Underserved 2010;21:112-31.
14. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-9.
15. Surveillance E, End Results (SEER) Program SEER*Stat Database: Incidence - SEER 17 Regs Limited-Use, Nov 2008 Sub (1973-2006) 〈Katrina/Rita Population Adjustment〉 - Linked To County Attributes - Total U S., 1969-2006 April 2009 ed: National Cancer Institute DCCPS, Surveillance Research Program, Cancer Statistics Branch; November 2008.
16. Ross LE, Berkowitz Z, Ekwueme DU. Use of the prostate-specific antigen test among U S. men: findings from the 2005 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev 2008; 17:636-44.
17. Thompson IM, Pauler DK, Goodman PJ, et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4.0 ng per milliliter. N Engl J Med 2004;350:2239-46.
18. Draisma G, Postma R, Schroder FH, van der Kwast TH, de Koning HJ. Gleason score, age and screening: modeling dedifferentiation in prostate cancer. Int J Cancer 2006;119:2366-71.
19. Halbert CH, Weathers B, Delmoor E, et al. Racial differences in medical mistrust among men diagnosed with prostate cancer. Cancer 2009;115:2553-61.
20. Halbert CH, Armstrong K, Gandy OH, Jr., Shaker L. Racial differences in trust in health care providers. Arch Intern Med 2006;166: 896-901.
21. Fowke JH, Signorello LB, Chang SS, et al. Effects of obesity and height on prostate-specific antigen (PSA) and percentage of free PSA levels among African-American and Caucasian men. Cancer 2006;107:2361-7.
22. Whittemore AS, Kolonel LN, Wu AH, et al. Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J Natl Cancer Inst 1995; 87:652-61.
23. Gudmundsson J, Sulem P, Manolescu A, et al. Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet 2007;39:631-7.
24. Montie JE, Pienta KJ. A unifying model to explain the increased incidence and higher mortality of prostate cancer in black men. Urology 1999;53:1073-6.
25. Ross LE, Taylor YJ, Richardson LC, Howard DL. Patterns in prostate- specific antigen test use and digital rectal examinations in the Behavioral Risk Factor Surveillance System, 2002-2006. J Natl Med Assoc 2009;101:316-24.
26. Mariotto AB, Etzioni R, Krapcho M, Feuer EJ. Reconstructing PSA testing patterns between black and white men in the US from Medicare claims and the National Health Interview Survey. Cancer 2007;109:1877-86.
27. Alibhai SM, Krahn MD, Fleshner NE, Cohen MM, Tomlinson GA, Naglie G. The association between patient age and prostate cancer stage and grade at diagnosis. BJU Int 2004;94:303-6. (Pubitemid 39120168)
28. Robbins AS, Koppie TM, Gomez SL, Parikh-Patel A, Mills PK. Differences in prognostic factors and survival among white and Asian men with prostate cancer, California, 1995-2004. Cancer 2007;110:1255-63.
29. Clegg LX, Li FP, Hankey BF, Chu K, Edwards BK. Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) Program population-based study. Arch Intern Med 2002;162:1985-93.
30. Bradley CJ, Given CW, Roberts C. Late stage cancers in a Medicaid-insured population. Med Care 2003;41:722-8.